Graduate students and trainee researchers in the Department of
Pharmacology and Toxicology and the neuroscience program presented
research talks and posters at the 2017 Behavior, Biology and
Chemistry: Translational Research in Addiction conference.
James D. Bangs, PhD, Grant T. Fisher Professor and chair of
microbiology and immunology, has received National Institutes of
Health (NIH) funding to continue his study of human African
trypanosomiasis, also known as sleeping sickness.
Graduate student and trainee researchers and their mentors in
the Department of Pharmacology and Toxicology received
positive feedback on in-depth studies they presented at the 2016
Behavior, Biology and Chemistry: Translational Research in
An international team led by Jonathan F. Lovell, PhD,
assistant professor of biomedical engineering, has created a
nanoparticle that may pave the way for “hypermodal”
imaging — the ability to merge results from six different
imaging modes using one contrast agent.
University at Buffalo researchers have designed a biomedical
device that could make chemotherapy more efficient, reduce its side
effects and improve how doctors treat some of the most deadly forms
A drug developed by University at Buffalo scientists from a
small protein found in spider venom is moving forward as a
promising treatment for Duchenne muscular dystrophy, a fatal
genetic disease affecting boys.